4//SEC Filing
TANSEY MICHAEL JAMES BYRON 4
Accession 0001209191-09-004703
CIK 0000920465other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:07 PM ET
Size
5.7 KB
Accession
0001209191-09-004703
Insider Transaction Report
Form 4
TANSEY MICHAEL JAMES BYRON
Executive VP & CMO
Transactions
- Award
Stock Option (right to buy)
2009-01-21+45,000→ 45,000 totalExercise: $1.26Exp: 2019-01-21→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The stock options vest and become exercisable monthly over the next four years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001369013
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:07 PM ET
- Size
- 5.7 KB